|

tadalafil 20 mg then 40 mg if tolerated Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Beni-Suef University1

Indications

  • Group 2 Pulmonary Hypertension1
  • Heart Disease1

Other1 trial

Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.